BrightSpring Health Services, Inc. (NASDAQ:BTSG - Get Free Report) insider Jon B. Rousseau sold 531,840 shares of the company's stock in a transaction on Thursday, June 12th. The stock was sold at an average price of $21.75, for a total transaction of $11,567,520.00. Following the completion of the transaction, the insider now owns 1,184,133 shares of the company's stock, valued at $25,754,892.75. This trade represents a 30.99% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link.
BrightSpring Health Services Trading Down 1.9%
Shares of NASDAQ BTSG traded down $0.42 during midday trading on Friday, reaching $21.18. The company had a trading volume of 5,196,302 shares, compared to its average volume of 1,537,491. BrightSpring Health Services, Inc. has a one year low of $10.15 and a one year high of $25.57. The company has a quick ratio of 0.97, a current ratio of 1.35 and a debt-to-equity ratio of 1.63. The firm's fifty day moving average price is $20.65 and its 200-day moving average price is $19.62. The stock has a market cap of $3.69 billion, a PE ratio of -81.46 and a beta of 2.58.
BrightSpring Health Services (NASDAQ:BTSG - Get Free Report) last announced its quarterly earnings results on Friday, May 2nd. The company reported $0.19 EPS for the quarter, topping analysts' consensus estimates of $0.09 by $0.10. The business had revenue of $2.88 billion for the quarter, compared to analysts' expectations of $2.74 billion. BrightSpring Health Services had a positive return on equity of 4.16% and a negative net margin of 0.38%. The business's quarterly revenue was up 25.9% on a year-over-year basis. During the same period in the previous year, the firm earned $0.12 EPS. On average, equities research analysts anticipate that BrightSpring Health Services, Inc. will post 0.59 earnings per share for the current year.
Analyst Ratings Changes
Several equities research analysts have issued reports on BTSG shares. Morgan Stanley lifted their price target on BrightSpring Health Services from $20.00 to $25.00 and gave the stock an "overweight" rating in a research note on Friday, May 9th. Wells Fargo & Company raised their price objective on BrightSpring Health Services from $25.00 to $27.00 and gave the company an "overweight" rating in a report on Tuesday, May 13th. Finally, Mizuho set a $26.00 target price on BrightSpring Health Services in a research note on Monday, May 5th. One equities research analyst has rated the stock with a hold rating and nine have given a buy rating to the company. Based on data from MarketBeat.com, BrightSpring Health Services presently has a consensus rating of "Moderate Buy" and an average target price of $23.56.
Get Our Latest Analysis on BTSG
Institutional Inflows and Outflows
Several hedge funds have recently made changes to their positions in the company. Quarry LP bought a new stake in BrightSpring Health Services in the 4th quarter worth $29,000. IFP Advisors Inc boosted its holdings in shares of BrightSpring Health Services by 273,666.7% during the first quarter. IFP Advisors Inc now owns 8,213 shares of the company's stock worth $149,000 after purchasing an additional 8,210 shares during the period. Highland Capital Management LLC bought a new stake in shares of BrightSpring Health Services in the first quarter worth about $181,000. Envestnet Asset Management Inc. purchased a new position in BrightSpring Health Services during the 4th quarter valued at about $188,000. Finally, KLP Kapitalforvaltning AS bought a new position in BrightSpring Health Services during the 4th quarter valued at approximately $206,000.
About BrightSpring Health Services
(
Get Free Report)
BrightSpring Health Services, Inc operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider BrightSpring Health Services, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and BrightSpring Health Services wasn't on the list.
While BrightSpring Health Services currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
